Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward ...

Andrew Dudum, the CEO of Hims & Hers Health Inc. (NYSE:HIMS), recently sold shares worth approximately $815,029, according to ...

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc. (NYSE:HIMS), reported a significant transaction involving ...

Citigroup has recently reduced Hims & Hers Health Inc (HIMS) stock to Sell rating, as announced on January 10, 2025, according to Finviz. Earlier, on January 7, 2025, BTIG Research had initiated the ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

By Jasper Brown News last week of Meta eliminating its third-party, fact-checking program on all of their sites should not ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Atricure (ATRC – Research Report) and Hims ...

In recent trading, Hims & Hers Health Inc (HIMS) stock price has shown some volatility, fluctuating 9.60% over the last five trades and -10.88% over the past 30 trades. This represents a notable shift ...

Discover why Hims & Hers Health is a top telehealth leader with impressive growth potential and a promising future for ...

Donald Trump's first inauguration in 2017 reportedly was estimated to cost as much as $200 million. Here's who pays the ...

Financial writer highlights undervalued Hims & Hers Health with impressive growth potential and innovative product launches, ...